Psammaplin A improves development and quality of somatic cell nuclear transfer mouse embryos

Cellular Reprogramming

Volumn 16, Issue 5, 2014, Pages 392-406

  Mallol, Anna ^a   Santaló, Josep ^a   Ibáñez, Elena ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN B; DNA; HISTONE; HISTONE DEACETYLASE INHIBITOR; LATRUNCULIN A; OCTAMER TRANSCRIPTION FACTOR 4; PSAMMAPLIN A; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; VALPROIC ACID; DISULFIDE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CLONING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUMULUS CELL; DEVELOPMENTAL STAGE; DNA METHYLATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; HISTONE ACETYLATION; HISTONE METHYLATION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; MICROMANIPULATION; MORULA; MOUSE; MOUSE EMBRYO; NONHUMAN; NUCLEAR REPROGRAMMING; OOCYTE; PARTHENOGENESIS; PLACENTA WEIGHT; PROTEIN EXPRESSION; SOMATIC CELL; TREATMENT DURATION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL EMBRYO; DOSE RESPONSE;

ANIMALS; DISULFIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FEMALE; HISTONE DEACETYLASE INHIBITORS; MICE; NUCLEAR TRANSFER TECHNIQUES; TYROSINE; VALPROIC ACID;

EID: 84907261724     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2014.0012     Document Type: Article

References (53)

1. Ahn, M.Y., Jung, J.H., Na, Y.J., and Kim, H.S. (2008). A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Gynecol. Oncol. 108, 27-33.
2. Baarlink, C., and Grosse, R. (2014). Formin' actin in the nucleus. Nucleus 5, 1-6.
3. Balbach, S.T., Esteves, T.C., Brink, T., Gentile, L., McLaughlin, K.J., Adjaye, J.A., and Boiani, M. (2010). Governing cell lineage formation in cloned mouse embryos. Dev. Biol. 343, 71-83.
4. Baud, M.G.J., Leiser, T., Haus, P., Samlal, S., Wong, A.C., Wood, R.J., Petrucci, V., Gunaratnam, M., Hughes, S.M., Buluwela, L., Turlais, F., Neidle, S., Meyer-Almes, F.J., White, A.J., and Fuchter, M.J. (2012). Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. J. Med. Chem. 55, 1731-1750.
5. Boiani, M., Eckardt, S., Schöler, H.R., and Mclaughlin, K.J. (2002). Oct4 distribution and level in mouse clones: Consequences for pluripotency. Genes Dev. 16, 1209-1219.
6. Boiani, M., Gentile, L., Gambles, V. V, Cavaleri, F., Redi, C.A., and Schöler, H.R. (2005). Variable reprogramming of the pluripotent stem cell marker Oct4 in mouse clones: Distinct developmental potentials in different culture environments. Stem Cells 23, 1089-1104.
7. Bortvin, A., Eggan, K., Skaletsky, H., Akutsu, H., Berry, D.L., Yanagimachi, R., Page, D.C., and Jaenisch, R. (2003). Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development 130, 1673-1680.
8. Cantone, I., and Fisher, A.G. (2013). Epigenetic programming and reprogramming during development. Nat. Struct. Mol. Biol. 20, 282-289.
9. Cavaleri, F.M., Balbach, S.T., Gentile, L., Jauch, A., Böhm-Steuer, B., Han, Y.-M., Schöler, H.R., and Boiani, M. (2008). Subsets of cloned mouse embryos and their non-random relationship to development and nuclear reprogramming. Mech. Dev. 125, 153-166.
10. Chan, M.M., Smith, Z.D., Egli, D., Regev, A., and Meissner, A. (2012). Mouse ooplasm confers context-specific reprogramming capacity. Nat. Genet. 44, 978-980.
11. Chatot, C.L., Ziomek, C.A., Bavister, B.D., Lewis, J.L., and Torres, I. (1989). An improved culture medium supports development of random-bred 1-cell mouse embryos in vitro. J. Reprod. Fertil. 86, 679-688.
12. Chung, Y.G., Ratnam, S., Chaillet, J.R., and Latham, K,E. (2003). Abnormal regulation of DNA methyltransferase expression in cloned mouse embryos. Biol Reprod. 69, 146-153.
13. Costa-Borges, N., Santalo, J., and Ibañez, E. (2010). Comparison between the effects of valproic acid and trichostatin A on the in vitro development, blastocyst quality, and full-term development of mouse somatic cell nuclear transfer embryos. Cell. Reprogram. 12, 1-10.
14. Dean, W., Santos, F., Stojkovic, M., Zakhartchenko, V., Walter, J., Wolf, E., and Reik, W. (2001). Conservation of methylation reprogramming in mammalian development: Aberrant reprogramming in cloned embryos. Proc. Natl. Acad. Sci. USA 98, 13734-13738.
15. Dobosy, J.R., and Selker, E.U. (2001). Emerging connections between DNA methylation and histone acetylation. Cell. Mol. Life Sci. 58, 721-727.
16. Enright, B.P., Kubota, C., Yang, X., and Tian, X.C. (2003). Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2¢-deoxycytidine. Biol. Reprod. 69, 896-901.
17. Garća, J., Franci, G., Pereira, R., Benedetti, R., Nebbioso, A., Rodŕguez-Barrios, F., Gronemeyer, H., Altucci, L., and de Lera, A.R. (2011). Epigenetic profiling of the antitumor natural product psammaplin A and its analogues. Bioorg. Med. Chem. 19, 3637-3649.
18. Gurdon, J.B., and Wilmut, I. (2011). Nuclear transfer to eggs and oocytes. Cold Spring Harb. Perspect. Biol. 3, 1-14.
19. Halsall, J., Gupta, V., O'Neill, L.P., Turner, B.M., and Nightingale, K.P. (2012). Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. PloS One 7, e33453.
20. Huang, Y., Tang, X., Xie, W., Zhou, Y., Li, D., Yao, C., Zhou, Y., Zhu, J., Lai, L., Ouyang, H., and Pang, D. (2011). Histone deacetylase inhibitor significantly improved the cloning efficiency of porcine somatic cell nuclear transfer embryos. Cell. Reprogram. 13, 513-520.
21. Humpherys, D., Eggan, K., Akutsu, H., Friedman, A., Hochedlinger, K., Yanagimachi, R., Lander, E.S., Golub, T.R., and Jaenisch, R. (2002). Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc. Natl. Acad. Sci. USA 99, 12889-12894.
22. Isaji, Y., Murata, M., Takaguchi, N., Mukai, T., Tajima, Y., Imai, H., and Yamada, M. (2013). Valproic acid treatment from the 4-cell stage improves Oct4 expression and nuclear distribution of histone H3K27me3 in mouse cloned blastocysts. J. Reprod. Dev. 59, 196-204.
23. Jafari, S., Hosseini, M.S., Hajian, M., Forouzanfar, M., Jafarpour, F., Abedi, P., Ostadhosseini, S., Abbasi, H., Gourabi, H., Shahverdi, A.H., Dizaj, A.V., Anjomshoaa, M., Haron, W., Noorshariza, N., Yakub, H., and Nasr-Esfahani, M.H. (2011). Improved in vitro development of cloned bovine embryos using S-adenosylhomocysteine, a non-toxic epigenetic modifying reagent. Mol. Reprod. Dev. 78, 576-584.
24. Kang, Y.K., Koo, D.B., Park, J.S., Choi, Y.H., Chung, A.S., Lee, K.K., and Han, Y.M. (2001). Aberrant methylation of donor genome in cloned bovine embryos. Nat. Genet. 28, 173-177.
25. Kang, Y.-K., Park, J.S., Koo, D.-B., Choi, Y.-H., Kim, S.-U., Lee, K.-K., and Han, Y.-M. (2002). Limited demethylation leaves mosaic-type methylation states in cloned bovine preimplantation embryos. EMBO J. 21, 1092-1100.
26. Kim, D., Lee, I.S., Jung, J.H., Lee, C.O., and Choi, S.U. (1999a). Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells. Anticancer Res. 19, 4085-4090.
27. Kim, D., Lee, I.S., Jung, J.H., and Yang, S.I. (1999b). Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity. Arch. Pharm. Res. 22, 25-29.
28. Kim, D.H., Shin, J., and Kwon, H.J. (2007). Psammaplin A is a natural prodrug that inhibits class I histone deacetylase. Exp. Mol. Med. 39, 47-55.
29. Kim, Y.J., Ahn, K.S., Kim, M., and Shim, H. (2011). Comparison of potency between histone deacetylase inhibitors trichostatin A and valproic acid on enhancing in vitro development of porcine somatic cell nuclear transfer embryos. In Vitro Cell. Dev. Biol. Anim. 47, 283-289.
30. Kishigami, S., Mizutani, E., Ohta, H., Hikichi, T., Thuan, N. Van, Wakayama, S., Bui, H.-T., and Wakayama, T. (2006a). Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem. Biophys. Res. Commun. 340, 183-189.
31. Kishigami, S., Hikichi, T., Van Thuan, N., Ohta, H., Wakayama, S., Bui, H.-T., Mizutani, E., and Wakayama, T. (2006b). Normal specification of the extraembryonic lineage after somatic nuclear transfer. FEBS Lett. 580, 1801-1806.
32. Maalouf, W.E., Alberio, R., and Campbell, K.H.S. (2008). Differential acetylation of histone H4 lysine during development of in vitro fertilized, cloned and parthenogenetically activated bovine embryos. Epigenetics 3, 199-209.
33. Mallol, A., Santaló, J., and Ibáñez, E. (2013). Comparison of three differential mouse blastocyst staining methods. Syst. Biol. Reprod. Med. 1-6.
34. Mann, M.R.W., Chung, Y.G., Nolen, L.D., Verona, R.I., Latham, K.E., and Bartolomei, M.S. (2003). Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol. Reprod. 69, 902-914.
35. Meng, Q., Wang, M., Stanca, C.A., Bodo, S., and Dinnyes, A. (2008). Cotransfer of parthenogenetic embryos improves the pregnancy and implantation of nuclear transfer embryos in mouse. Cloning Stem Cells 10, 429-434.
36. Miyamoto, K., Pasque, V., Jullien, J., and Gurdon, J.B. (2011). Nuclear actin polymerization is required for transcriptional reprogramming of Oct4 by oocytes. Genes Dev. 25, 946-958.
37. Miyoshi, K., Mori, H., Mizobe, Y., Akasaka, E., Ozawa, A., Yoshida, M., and Sato,M. (2010).Valproic acid enhances in vitro development and Oct-3/4 expression of miniature pig somatic cell nuclear transfer embryos. Cell. Reprogram. 12, 67-74.
38. Nicholas, G.M., Eckman, L.L., Ray, S., Hughes, R.O., Pfefferkorn, J.A., Barluenga, S., Nicolaou, K.C., and Bewley, C.A. (2002). Bromotyrosine-derived natural and synthetic products as inhibitors of mycothiol-S-conjugate amidase. Bioorg. Med. Chem. Lett. 12, 2487-2490.
39. Niemann, H., Tian, X.C., King, W.A., Lee, R.S. (2008). Epigenetic reprogramming in embryonic and foetal development upon somatic cell nuclear transfer cloning. Reproduction 135, 151-163.
40. Ogura, A., Inoue, K., and Wakayama, T. (2013). Recent advancements in cloning by somatic cell nuclear transfer. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 368, 20110329.
41. Piña, I.C., Gautschi, J.T., Wang, G.-Y.-S., Sanders, M.L., Schmitz, F.J., France, D., Cornell-Kennon, S., Sambucetti, L.C., Remiszewski, S.W., Perez, L.B., Bair, K.W., and Crews, P. (2003). Psammaplins from the sponge Pseudoceratina purpurea: Inhibition of both histone deacetylase and DNA methyltransferase. J. Org. Chem. 68, 3866-3873.
42. Rybouchkin, A., Kato, Y., and Tsunoda, Y. (2006). Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. Biol. Reprod. 74, 1083-1089.
43. Su, J., Wang, Y., Li, Y., Li, R., Li, Q., Wu, Y., Quan, F., Liu, J., Guo, Z., and Zhang, Y. (2011). Oxamflatin significantly improves nuclear reprogramming, blastocyst quality, and in vitro development of bovine SCNT embryos. PLoS One 6, e23805.
44. Terashita, Y., Wakayama, S., Yamagata, K., Li, C., Sato, E., and Wakayama, T. (2012). Latrunculin A can improve the birth rate of cloned mice and simplify the nuclear transfer protocol by gently inhibiting actin polymerization. Biol. Reprod. 86, 180.
45. Terashita, Y., Yamagata, K., Tokoro, M., Itoi, F., Wakayama, S., Li, C., Sato, E., Tanemura, K., and Wakayama, T. (2013). Latrunculin a treatment prevents abnormal chromosome segregation for successful development of cloned embryos. PLoS One 8, e78380.
46. Thouas, G.A., Korfiatis, N.A., French, A.J., Jones, G.M., and Trounson, A.O. (2001). Simplified technique for differential staining of inner cell mass and trophectoderm cells of mouse and bovine blastocysts. Reprod. BioMed. Online 3, 25-29.
47. Van Thuan, N., Bui, H.-T., Kim, J.-H., Hikichi, T., Wakayama, S., Kishigami, S., Mizutani, E., and Wakayama, T. (2009). The histone deacetylase inhibitor scriptaid enhances nascent mRNA production and rescues full-term development in cloned inbred mice. Reproduction 138, 309-317.
48. Van Thuan, N., Kishigami, S., and Wakayama, T. (2010). How to improve the success rate of mouse cloning technology. J. Reprod. Dev. 56, 20-30.
49. VerMilyea, M.D., O'Neill, L.P., and Turner, B.M. (2009). Transcription-independent heritability of induced histone modifications in themouse preimplantation embryo. PLoSOne 4, e6086.
50. Wakayama, S., andWakayama, T. (2010). Improvement of mouse cloning using nuclear transfer-derived embryonic stemcells and/or histone deacetylase inhibitor. Int. J. Dev.Biol. 54, 1641-1648.
51. Wang, F., Kou, Z., Zhang, Y., and Gao, S. (2007). Dynamic reprogramming of histone acetylation and methylation in the first cell cycle of cloned mouse embryos. Biol. Reprod. 77, 1007-1016.
52. Xu, W., Wang, Y., Li, Y., Wang, L., Xiong, X., Su, J., and Zhang, Y. (2012). Valproic acid improves the in vitro development competence of bovine somatic cell nuclear transfer embryos. Cell. Reprogram. 14, 138-145.
53. Yang, X., Smith, S.L., Tian, X.C., Lewin, H.A., Renard, J.-P., and Wakayama, T. (2007). Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 39, 295-302.